Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark

Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in Denmark

Show other versions (1)

<h4>Introduction</h4> Programmed cell death ligand-1 (PD-L1) expression may help identify patients with non-small cell lung cancer (NSCLC) who would benefit from immunotherapy. We assessed PD-L1 expression, and epidermal growth factor receptor (EGFR) and V-Ki-Ras2 Kirsten rat sarcoma (KR...

Full description

Bibliographic Details
Main Authors: Tapashi Dalvi, Mette Nørgaard, Jon P. Fryzek, Naimisha Movva, Lars Pedersen, Hanh Pham Hansen, Jill Walker, Anita Midha, Norah Shire, Anne-Marie Boothman, James Rigas, Anders Mellemgaard, Torben R. Rasmussen, Stephen Hamilton-Dutoit, Deirdre Cronin-Fenton
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089313/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089313/?tool=EBI

Similar Items